Abstract | BACKGROUND: OBJECTIVE: We aimed to evaluate the clinical significance of anti-ARS antibodies in PM/DM-ILD patients. METHODS: Forty-eight consecutive PM/DM-ILD patients were studied retrospectively. Anti-ARS antibodies were screened by ELISA and confirmed by RNA immunoprecipitation test. Medical records, high-resolution computed tomography images, and surgical lung biopsy specimens were compared between ARS-positive (ARS group) and ARS-negative patients (non-ARS group). RESULTS: Anti-ARS antibodies were detected in 23 of 48 patients (48%). Radiologically, nonspecific interstitial pneumonia (NSIP) pattern was observed more frequently in the ARS group than in the non-ARS group (73.9% vs. 40%, P = 0.02). Pathologically, NSIP was the most frequent in both groups. Ten-year survival rate was also significantly higher in the ARS group than in the non-ARS group (91.6% vs. 58.7%, P = 0.02). Univariate Cox hazards analysis revealed that the presence of anti-ARS antibodies was associated with better prognosis (HR = 0.34, 95% CI 0.08-0.80; P = 0.01). CONCLUSIONS: The presence of anti-ARS antibodies is a possible prognostic marker in patients with PM/DM-ILD.
|
Authors | Hironao Hozumi, Noriyuki Enomoto, Masato Kono, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Hiromitsu Sumikawa, Takeshi Johkoh, Ran Nakashima, Yoshitaka Imura, Tsuneyo Mimori, Takafumi Suda |
Journal | PloS one
(PLoS One)
Vol. 10
Issue 3
Pg. e0120313
( 2015)
ISSN: 1932-6203 [Electronic] United States |
PMID | 25789468
(Publication Type: Journal Article)
|
Chemical References |
- Autoantibodies
- Biomarkers
- Amino Acyl-tRNA Synthetases
|
Topics |
- Adult
- Aged
- Amino Acyl-tRNA Synthetases
(immunology)
- Autoantibodies
(analysis, immunology)
- Biomarkers
(analysis)
- Case-Control Studies
- Dermatomyositis
(complications, mortality, pathology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Immunoprecipitation
- Kaplan-Meier Estimate
- Lung Diseases, Interstitial
(complications, diagnosis, mortality)
- Male
- Middle Aged
- Polymyositis
(complications, mortality, pathology)
- Prognosis
- Proportional Hazards Models
- Retrospective Studies
- Tomography, X-Ray Computed
|